首页 | 本学科首页   官方微博 | 高级检索  
检索        

LAK细胞治疗慢性乙,丙型肝炎疗效及免疫机制研究
引用本文:孙永良,何南祥.LAK细胞治疗慢性乙,丙型肝炎疗效及免疫机制研究[J].中华传染病杂志,1995,13(1):4-7.
作者姓名:孙永良  何南祥
作者单位:杭州浙江医科大学传染病研究所,浙江医科大学附属一院,华北油田第二医院,杭州铁路中心医院
摘    要:报道应用自体LAK细胞回输治疗110例慢性乙型肝炎(乙肝)和20例慢性丙型肝炎(丙肝)的结果。疗程结束时慢性乙肝治疗组HBeAg阴转率、抗-HBe阳转率和HBvDNA阴转率分别为46,4%、35.5%和48.2%,与对照组相比明显提高(P均〈0.005);2o例慢性丙肝经治疗后抗-HCV阴转2例(10%),HCVRNA阴转4例(20%),而对照组维持不变。进而对LAK治疗的免疫机制进行探讨,结果发现LAK治疗后CAH患者CD+4阳性率、CD+4/cD+8比值均增高(P<0.05),外周血单个核细胞膜白细胞介素-2受体(mIL-2R)和血清中可溶性白细胞介素-2受体(sIL-2R)的水平也明显升高(P<0.01)。

关 键 词:LAK细胞,乙型肝炎,丙型肝炎,治疗,机制

EFFICY ANDIMMUNE MECHANISM IN TREATNENT 0F CHRONIC TYPE B AND TYPE C VIRAL HEPATITIS WITH LAK CELLS
Sun Yongliang,He Nanxiang,Yao Hangping,et al..EFFICY ANDIMMUNE MECHANISM IN TREATNENT 0F CHRONIC TYPE B AND TYPE C VIRAL HEPATITIS WITH LAK CELLS[J].Chinese Journal of Infectious Diseases,1995,13(1):4-7.
Authors:Sun Yongliang  He Nanxiang  Yao Hangping  
Institution:Sun Yongliang,He Nanxiang,Yao Hangping,et al. Institute of Infectious Diseases,Zhejiang Medlcal University,Hangzhou,310006
Abstract:LAK cell infusion was used to treat 110 cases of chronic type B hepatitis and 20cases of chronic type C hepatitis. The results indicated that HBeAg became negative,anti-HBe turned positive and HBV DNA negative in 46.4%, 35.5%and48.2% respe-ctivcly at the end of the therapy , all being higher as compared with the control(P<0.05)Among 20 cases received LAK cell therapy anti-HCV became negative in 2 cases,and in 4 cases HCV RNA became negative.There was no change of anti-HCV and HCVRNA in the control group. The immune mechanism for LAK cell therapy was inves-tigated.It was found that both the CD 4 Percentage and the ratio of CD 4/CD 8 in-creased.The expression of membrane interleukin-2(IL-2) receptor and the level ofsoluble IL-2 receptor in the treated patients were both enhanced likewise.
Keywords:LAK cells  Type B hepatitis  Type C hepatitis  Therapy mechanism  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号